Induction of diabetes by Streptozotocin in rats
Abstract
The objective of this study is to induce experimental diabetes mellitus by Streptozotocin in normal adult Wistar rats via comparison of changes in body weight, consumption of food and water, volume of urine and levels of glucose, insulin and C-peptide in serum, between normal and diabetic rats. Intra-venous injection of 60mg/kg dose of Streptozotocin in adult wistar rats, makes pancreas swell and at last causes degeneration in Langerhans islet beta cells and induces experimental diabetes mellitus in the 2–4 days. Induction of experimental diabetes mellitus is indeed the first step in the plan of purification of pancreatic Langerhans islet cells of normal rats for transplanting under the testis subcutaneous of experimentally induced diabetic rats. Streptozotocin induces one type of diabetes which is similar to diabetes mellitus with non-ketosis hyperglycemia in some animal species. For induction of experimental diabetes in male adult rats weighted 250–300 grams (75–90 days), 60mg/kg of Streptozotocin was injected intravenously. Three days after degeneration of beta cells, diabetes was induced in all animals. The diabetic and normal animals were kept in the metabolic cages separately and their body weight, consumption of food and water, urine volume, the levels of serum glucose, insulin and C-peptide quantities in all animals were measured and then these quantities were compared. For a microscopic study of degeneration of Langerhans islet beta cells of diabetic rats, sampling from pancreas tissue of diabetic and normal rats, staining and comparison between them, were done. Induction of diabetes with Streptozotocin decreases Nicotinamide-adenine dinucleotide (NAD) in pancreas islet beta cells and causes histopathological effects in beta cells which probably intermediates induction of diabetes. In this study, we used Streptozotocin for our experiments in induction of experimental diabetes mellitus. After Induction of diabetes, consumption of food and water, volume of urine and glucose increased in the diabetic animals in comparison with normal animals, but the weight of body and the volume of insulin and C-peptide decreased in the diabetic animals. Sampling and staining of pancreas tissue of diabetic and normal rats showed that the Langerhans islet beta cells of diabetic rats have been clearly degenerated. In three days, Streptozotocin makes pancreas swell and at last causes degeneration in Langerhans islet beta cells and induces experimental diabetes. It also changes normal metabolism in diabetic rats in comparison with normal rats. Consumption of water and food, volume of urine, serum glucose increases in diabetic animals in comparison with normal rats but the levels of serum insulin, C-peptide and body weight decreases.
Abstract
The objective of this study is to induce experimental diabetes mellitus by Streptozotocin in normal adult Wistar rats via comparison of changes in body weight, consumption of food and water, volume of urine and levels of glucose, insulin and C-peptide in serum, between normal and diabetic rats. Intra-venous injection of 60mg/kg dose of Streptozotocin in adult wistar rats, makes pancreas swell and at last causes degeneration in Langerhans islet beta cells and induces experimental diabetes mellitus in the 2–4 days. Induction of experimental diabetes mellitus is indeed the first step in the plan of purification of pancreatic Langerhans islet cells of normal rats for transplanting under the testis subcutaneous of experimentally induced diabetic rats. Streptozotocin induces one type of diabetes which is similar to diabetes mellitus with non-ketosis hyperglycemia in some animal species. For induction of experimental diabetes in male adult rats weighted 250–300 grams (75–90 days), 60mg/kg of Streptozotocin was injected intravenously. Three days after degeneration of beta cells, diabetes was induced in all animals. The diabetic and normal animals were kept in the metabolic cages separately and their body weight, consumption of food and water, urine volume, the levels of serum glucose, insulin and C-peptide quantities in all animals were measured and then these quantities were compared. For a microscopic study of degeneration of Langerhans islet beta cells of diabetic rats, sampling from pancreas tissue of diabetic and normal rats, staining and comparison between them, were done. Induction of diabetes with Streptozotocin decreases Nicotinamide-adenine dinucleotide (NAD) in pancreas islet beta cells and causes histopathological effects in beta cells which probably intermediates induction of diabetes. In this study, we used Streptozotocin for our experiments in induction of experimental diabetes mellitus. After Induction of diabetes, consumption of food and water, volume of urine and glucose increased in the diabetic animals in comparison with normal animals, but the weight of body and the volume of insulin and C-peptide decreased in the diabetic animals. Sampling and staining of pancreas tissue of diabetic and normal rats showed that the Langerhans islet beta cells of diabetic rats have been clearly degenerated. In three days, Streptozotocin makes pancreas swell and at last causes degeneration in Langerhans islet beta cells and induces experimental diabetes. It also changes normal metabolism in diabetic rats in comparison with normal rats. Consumption of water and food, volume of urine, serum glucose increases in diabetic animals in comparison with normal rats but the levels of serum insulin, C-peptide and body weight decreases.
Full Text
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
References
- 1. World Health Organization: htt:/www.who.int/medacenter/factsheets/fs/138/en/Page 1–3.
- 2. Ikebukuro K, Adachi Y, Yamada Y, Fujimoto S, Seino Y, Oyaizu HTreatment of Streptozotocin-induced diabetes mellitus by transplantation of islet cells Plus bone Marrow cells via portal vein in rats. Transplantation. 2002;73(4):512–8. doi: 10.1097/00007890-200202270-00004.] [[PubMed][Google Scholar]
- 3. Rastellini C, Shapiro R, Corry R, Fung JJ, Starzl TE, Rao ASAn attempt to reverse diabetes by delayed islet cell transplantation in Humans. Transplantation proceedings. 1997;29:2238–9. doi: 10.1016/S0041-1345(97)00313-8.] [[Google Scholar]
- 4. Elias D, Prigozin H, Polak N, Rapoport M, Lohse AW, Cohen IRAutoimmune diabetes induced by the b—Cell toxin STZ. Diabetes. 1994;43:992–8. doi: 10.2337/diabetes.43.8.992.] [[PubMed][Google Scholar]
- 5. Weiss RBStreptozocin: A review of its pharmacology, efficacy and toxicity. Cancer Treatment Report. 1982;66(3):427–38.[PubMed][Google Scholar]
- 6. Karunanayake EH, Hearse DJ, Mellows GThe metabolic fate and elimination of streptozocin. Biochemical Society Transactions. 1975;3:410–14.[PubMed][Google Scholar]
- 7. Bhuyan BK, Kuentzel SL, Gray LG, Wallach D, Neil GLTissue distribution of streptozotocin (NSC 85998) Cancer Chemotherapy Report. 1974;58:157–65.[PubMed][Google Scholar]
- 8. Levi JA, Wiernik PH, Diggs CHCombination chemotherapy of advanced Previously Treated Hodgkin's disease with streptozocin, CCNU, Adriamycin and bleomycin. Medical and pediatric oncology. 1977;3:33–40. doi: 10.1002/mpo.2950030106.] [[PubMed][Google Scholar]
- 9. Thulesen J, Qrskov C, Holst JJ, Poulsen SSShort Term Insulin Treatment Prevents the diabetogenic action of streptozotocin in rats. Endocrinology. 1997;138(1):62–8. doi: 10.1210/en.138.1.62.] [[PubMed][Google Scholar]
- 10. Holemans K, Bree RV, Verhaeghe J, Meurrens K, Assche AVMaternal Semi starvation and Streptozotocin-Diabetes in Rats have different effects on the in Vivo glucose uptake by peripheral tissues in their female adult offspring. The Journal of Nutrition. 1997;127:1371–6.[PubMed][Google Scholar]
- 11. Diabetes mellitus-wikipedia, the free encyclopedia, http://encyclopedia.onlinereference.info/index.php Diabetes#Statistics